Panacea Biotec Limited (NSE:PANACEABIO)
436.35
-7.45 (-1.68%)
Apr 9, 2025, 3:30 PM IST
Panacea Biotec Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Revenue | 5,630 | 5,592 | 4,599 | 6,612 | 6,248 | 5,441 | Upgrade
|
Revenue Growth (YoY) | 2.06% | 21.57% | -30.44% | 5.83% | 14.84% | 19.13% | Upgrade
|
Cost of Revenue | 1,972 | 2,301 | 2,527 | 2,622 | 2,046 | 1,568 | Upgrade
|
Gross Profit | 3,658 | 3,290 | 2,073 | 3,990 | 4,202 | 3,873 | Upgrade
|
Selling, General & Admin | 1,770 | 1,643 | 1,517 | 2,050 | 1,774 | 1,649 | Upgrade
|
Other Operating Expenses | 1,785 | 1,695 | 1,192 | 1,987 | 1,544 | 1,362 | Upgrade
|
Operating Expenses | 3,908 | 3,705 | 3,100 | 4,474 | 3,774 | 3,443 | Upgrade
|
Operating Income | -249.69 | -414.69 | -1,027 | -484.18 | 427.33 | 429.26 | Upgrade
|
Interest Expense | -27.53 | -26.73 | -38.03 | -1,798 | -1,847 | -1,731 | Upgrade
|
Interest & Investment Income | 83.81 | 83.81 | 120.62 | 33.94 | 32.68 | 47.92 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | 0.77 | 3.3 | Upgrade
|
Currency Exchange Gain (Loss) | 36.23 | 36.23 | 20.77 | 5.8 | -6.88 | -8.39 | Upgrade
|
Other Non Operating Income (Expenses) | -38.28 | -9.08 | -6.34 | -10.02 | -6.45 | -8.7 | Upgrade
|
EBT Excluding Unusual Items | -195.46 | -330.46 | -930.37 | -2,253 | -1,399 | -1,268 | Upgrade
|
Gain (Loss) on Sale of Investments | 33.67 | 33.67 | 14.47 | 0.01 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -2.64 | -2.64 | 52.93 | 0.07 | -0.38 | -290.52 | Upgrade
|
Asset Writedown | -46.14 | -46.14 | -29.94 | -15.75 | -42.63 | - | Upgrade
|
Other Unusual Items | 110.24 | 360.34 | 1,021 | 16,762 | - | -153.97 | Upgrade
|
Pretax Income | -100.33 | 14.77 | 128.05 | 14,494 | -1,442 | -1,712 | Upgrade
|
Income Tax Expense | -13.08 | 29.82 | 465.5 | 3,710 | 19.57 | 166.4 | Upgrade
|
Earnings From Continuing Operations | -87.25 | -15.05 | -337.45 | 10,783 | -1,462 | -1,879 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | -14.55 | -64.36 | Upgrade
|
Net Income to Company | -87.25 | -15.05 | -337.45 | 10,783 | -1,477 | -1,943 | Upgrade
|
Minority Interest in Earnings | 8.12 | 3.32 | 5.08 | -0.19 | -0.38 | 0.29 | Upgrade
|
Net Income | -79.13 | -11.73 | -332.37 | 10,783 | -1,477 | -1,943 | Upgrade
|
Net Income to Common | -79.13 | -11.73 | -332.37 | 10,783 | -1,477 | -1,943 | Upgrade
|
Shares Outstanding (Basic) | 58 | 61 | 61 | 61 | 61 | 61 | Upgrade
|
Shares Outstanding (Diluted) | 58 | 61 | 61 | 61 | 61 | 61 | Upgrade
|
EPS (Basic) | -1.36 | -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | Upgrade
|
EPS (Diluted) | -1.36 | -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | Upgrade
|
Free Cash Flow | - | -778.18 | -4,634 | -1,210 | 848.87 | -371.38 | Upgrade
|
Free Cash Flow Per Share | - | -12.71 | -75.66 | -19.75 | 13.86 | -6.06 | Upgrade
|
Gross Margin | 64.97% | 58.85% | 45.07% | 60.35% | 67.25% | 71.18% | Upgrade
|
Operating Margin | -4.44% | -7.42% | -22.34% | -7.32% | 6.84% | 7.89% | Upgrade
|
Profit Margin | -1.41% | -0.21% | -7.23% | 163.08% | -23.64% | -35.71% | Upgrade
|
Free Cash Flow Margin | - | -13.92% | -100.75% | -18.29% | 13.59% | -6.83% | Upgrade
|
EBITDA | 99.33 | -47.58 | -636.16 | -56.28 | 872.65 | 861.45 | Upgrade
|
EBITDA Margin | 1.76% | -0.85% | -13.83% | -0.85% | 13.97% | 15.83% | Upgrade
|
D&A For EBITDA | 349.02 | 367.11 | 391.23 | 427.9 | 445.32 | 432.19 | Upgrade
|
EBIT | -249.69 | -414.69 | -1,027 | -484.18 | 427.33 | 429.26 | Upgrade
|
EBIT Margin | -4.44% | -7.42% | -22.34% | -7.32% | 6.84% | 7.89% | Upgrade
|
Effective Tax Rate | - | 201.90% | 363.53% | 25.60% | - | - | Upgrade
|
Revenue as Reported | 5,859 | 5,850 | 5,116 | 6,722 | 6,348 | 5,737 | Upgrade
|
Advertising Expenses | - | 113.04 | 218.21 | 220.05 | 183.74 | 209.78 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.